Collection of 7 Transdermal and Transmucosal Drug Delivery Markets Report 2013-2020 -- Research and Markets
DUBLIN, April 25, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Transdermal and Transmucosal Drug Delivery Markets" report to their offering.
Transdermal and Transmucosal Drug Delivery Markets analyzes the current and potential markets for transdermal/transmucosal drug delivery, a well-established accepted route of administration for therapeutically beneficial medicines.
Transdermal and Transmucosal Drug Delivery Markets provides the following market information:
- The Worldwide Market for Transdermal/Transmucosal Drug Delivery Technology and Pharmaceuticals, 2013-2020
- The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmucosal Drug Delivery Systems by Type, 2013-2020
- The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmucosal Drug Delivery Technologies, Market Share by Type, 2013-2020
- Transdermal/Transmucosal Drug Delivery by Indication by Percent, 2015 (Smoking Cessation, Pain Management, Hormone, Cardio, Others)
- The Transdermal/Transmucosal Drug Delivery Market by Region, 2013-2020 (United States, Europe, Japan, Rest of World, Global Market)
- The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 2013-2020
- Leading Suppliers of Transdermal/Transmucosal Drug Delivery Technology
The transdermal/transmucosal drug delivery market consists of many companies including large and small pharmaceutical companies as well as large and small drug delivery companies. The competition among participants is intensifying not only within the specific category such as transdermal drug delivery but also among the competing drug delivery technologies to provide the best possible vehicle for administration of a particular pharmaceutical product.
The report profiles companies involved in the transdermal/transmucosal drug delivery market. Drug delivery companies have made tremendous strides in the transdermal/transmucosal drug delivery market. Several companies have products that are already enjoying market success while many others are at various stages of development. There is little doubt that this area of drug delivery will continue to flourish in the coming years.
Challenges remain for the development of transdermal/transmucosal drug delivery systems but continued research will likely break down the barriers that limit the types of drug molecules that may be delivered through the skin. The market is expected to be driven by various factors including the loss of patent protection for blockbuster drugs and the need to avoid the first pass effects of oral drug delivery. Additionally, with an added focus on active transdermal technologies, new applications will likely cause a resurgence of interest in transdermal delivery of products.
Key Topics Covered:
ONE: EXECUTIVE SUMMARY
- Market Drivers
- Market Size and Growth
- Total Transdermal/Transmucosal Drug Delivery Market
- Transdermal/Transmucosal Drug Delivery Only Market
- Competitive and Market Analysis
TWO: INTRODUCTION AND OVERVIEW
- Scope and Methodology
- Reasons for Transdermal/Transmucosal Drug Delivery Systems
- Phases of Drug Action
- Transdermal Drug Delivery
- History of Transdermal Drug Delivery
- Advantages of Transdermal Drug Delivery
- Disadvantages of Transdermal Drug Delivery
- Passive Transdermal Drug Delivery
- Transfersomes
- Medicated Tattoos
- Crystal Reservoir Technology
- Active Transdermal Drug Delivery
- Transdermal Microneedle Drug Delivery
- Electrotransport Drug Delivery
- Iontophoresis
- Sonophoresis
- Magnetophoresis
- Photomechanical Waves
- Transmucosal Drug Delivery
- Buccal Drug Delivery
- Vaginal Drug Delivery
THREE: TRENDS AND DEVELOPMENTS
- Novel Transdermal Approvals
- Innovations in Transdermal Drug Delivery
- Adhesive Technology and Issues
- Adhesive Market Issues
- Generic Transdermal Study Design Guidelines
- Biotechnological Issues
- Developments in Insulin Delivery
- New Developments in Hormone Drug Delivery
- New Mucosal/Buccal Delivery Systems
- Other Drug Delivery Systems
- Microneedle-Assisted Transdermal Drug Delivery
- Controlled Thermal Energy Technology
- New Ultrasound Technology
- Transdermal Products in Development
FOUR: MARKET SIZE AND GROWTH
- The Total Transdermal/Transmucosal Drug Delivery Market
- Transdermal Subsegment Market
- Transdermal/Transmucosal Market by Application
- MARKET ANALYSIS BY REGION
- Transdermal/Transmucosal Delivery Technology Only Market
FIVE: COMPETITIVE ANALYSIS
- Competitive Landscape
- Emerging Participants
- Market Analysis
SIX: COMPANY PROFILES
- 3M Pharmaceuticals
- Acrux Limited
- ALZA Corporation
- Antares Pharma, Inc.
- Apricus BioSciences, Inc
- Aveva Drug Delivery Systems
- Corium International, Inc
- DURECT Corporation
- Generex Biotechnology Corporation
- Inovio Pharmaceuticals, Inc.
- Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
- MedPharm LTD
- Mylan, Inc.
- Nemaura Pharma Ltd
- Nitto Denko Corporation
- Noven Pharmaceuticals, Inc.
- Pantec Biosolutions AG
- Tapemark
- tesa Labtec GmbH
- TEVA Pharmaceutical Industries Ltd.
- Zosano Pharma
APPENDIX: COMPANY DIRECTORY
For more information visit http://www.researchandmarkets.com/research/9zmmsv/transdermal_and
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article